Bullous pemphigoid burden of disease, management and unmet therapeutic needs
Journal of the European Academy of Dermatology and Venereology · 2025-02 · 39 (2) · 290-300
DOI: 10.1111/jdv.20313 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 19.09.2024. Verfasst von V P Werth und 4 weiteren Autor:innen. Beteiligte Einrichtung: Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Cost of Illness. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Regeneron Pharmaceuticals Inc., Sanofi, Regeneron Pharmaceuticals.
Abstract (Originalsprache)
Bullous pemphigoid (BP) is an autoimmune blistering disease that can have a profound negative impact on quality of life. BP most often affects the elderly, a population with a high medical burden and special safety concerns. In this review, we outline the BP disease course, diagnosis, epidemiology and comorbidities, and describe tools commonly used to assess BP disease activity and severity and the impact of BP on health‐related quality of life. We also outline biologic treatments currently under investigation for the treatment of BP and highlight the importance of considering safety when treating elderly patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.
- St George Hospital, University of New South Wales, Sydney, New South Wales, Australia.
- Rouen University Hospital and INSERM 1234, Normandy University, Rouen, France.
- Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.
- Sanofi, Cambridge, Massachusetts, USA.
Förderung
- Regeneron Pharmaceuticals Inc.
- Sanofi
- Regeneron Pharmaceuticals
Zitieren
APA
Werth, V. P., Murrell, D. F., Joly, P., Ardeleanu, M., & Hultsch, V. (2025). Bullous pemphigoid burden of disease, management and unmet therapeutic needs. Journal of the European Academy of Dermatology and Venereology, 39(2), 290-300. https://doi.org/10.1111/jdv.20313
Vancouver
Werth VP, Murrell DF, Joly P, Ardeleanu M, Hultsch V. Bullous pemphigoid burden of disease, management and unmet therapeutic needs. Journal of the European Academy of Dermatology and Venereology. 2025;39(2):290-300. doi:10.1111/jdv.20313
BibTeX
@article{Werth2025,
author = {Werth, V P and Murrell, D F and Joly, P and Ardeleanu, M and Hultsch, V},
title = {Bullous pemphigoid burden of disease, management and unmet therapeutic needs},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2025},
volume = {39},
number = {2},
pages = {290--300},
doi = {10.1111/jdv.20313}
}
EUVIMED